These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 23872176

  • 21. The preparation by extrusion/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and glyceryl monostearate.
    Chatchawalsaisin J, Podczeck F, Newton JM.
    Eur J Pharm Sci; 2005 Jan; 24(1):35-48. PubMed ID: 15626576
    [Abstract] [Full Text] [Related]

  • 22. The evaluation of formulations for the preparation of pellets with high drug loading by extrusion/spheronization.
    Podczeck F, Knight P.
    Pharm Dev Technol; 2006 Jan; 11(3):263-74. PubMed ID: 16895837
    [Abstract] [Full Text] [Related]

  • 23. Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization.
    Charoenthai N, Kleinebudde P, Puttipipatkhachorn S.
    J Pharm Sci; 2007 Sep; 96(9):2469-84. PubMed ID: 17286294
    [Abstract] [Full Text] [Related]

  • 24. A study of the effects of the physical characteristics of microcrystalline cellulose on performance in extrusion spheronization.
    Heng PW, Koo OM.
    Pharm Res; 2001 Apr; 18(4):480-7. PubMed ID: 11451035
    [Abstract] [Full Text] [Related]

  • 25. Design and optimization of disintegrating pellets of MCC by non-aqueous extrusion process using statistical tools.
    Gurram RK, Gandra S, Shastri NR.
    Eur J Pharm Sci; 2016 Mar 10; 84():146-56. PubMed ID: 26812204
    [Abstract] [Full Text] [Related]

  • 26. Alginate-based pellets prepared by extrusion/spheronization: effect of the amount and type of sodium alginate and calcium salts.
    Sriamornsak P, Nunthanid J, Luangtana-anan M, Weerapol Y, Puttipipatkhachorn S.
    Eur J Pharm Biopharm; 2008 May 10; 69(1):274-84. PubMed ID: 17962003
    [Abstract] [Full Text] [Related]

  • 27. Melt-in-Mouth Multi-particulate System for the Treatment of ADHD: A Convenient Platform for Pediatric Use.
    Patadia J, Tripathi R, Joshi A.
    AAPS PharmSciTech; 2016 Aug 10; 17(4):878-90. PubMed ID: 26392403
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of microcrystalline cellulose II (MCCII) as an alternative extrusion-spheronization aid.
    Rojas J, Kumar V.
    Pharmazie; 2012 Jul 10; 67(7):595-7. PubMed ID: 22888514
    [Abstract] [Full Text] [Related]

  • 29. The evaluation of the rheological properties of lactose/microcrystalline cellulose and water mixtures by controlled stress rheometry and the relationship to the production of spherical pellets by extrusion/spheronization.
    MacRitchie KA, Newton JM, Rowe RC.
    Eur J Pharm Sci; 2002 Oct 10; 17(1-2):43-50. PubMed ID: 12356419
    [Abstract] [Full Text] [Related]

  • 30. Effect of drying on extruded pellets based on kappa-carrageenan.
    Thommes M, Blaschek W, Kleinebudde P.
    Eur J Pharm Sci; 2007 Jun 10; 31(2):112-8. PubMed ID: 17448646
    [Abstract] [Full Text] [Related]

  • 31. Supramolecular elucidation of the quality attributes of microcrystalline cellulose and isomalt composite pellet cores.
    Antal I, Kállai N, Luhn O, Bernard J, Nagy ZK, Szabó B, Klebovich I, Zelkó R.
    J Pharm Biomed Anal; 2013 Oct 10; 84():124-8. PubMed ID: 23827942
    [Abstract] [Full Text] [Related]

  • 32. Physicochemical properties of granulating liquids and their influence on microcrystalline cellulose pellets obtained by extrusion-spheronisation technology.
    Dreu R, Sirca J, Pintye-Hodi K, Burjan T, Planinsek O, Srcic S.
    Int J Pharm; 2005 Mar 03; 291(1-2):99-111. PubMed ID: 15707736
    [Abstract] [Full Text] [Related]

  • 33. Use of the direct compression aid Ludiflash(®) for the preparation of pellets via wet extrusion/spheronization.
    Roblegg E, Schrank S, Griesbacher M, Radl S, Zimmer A, Khinast J.
    Drug Dev Ind Pharm; 2011 Oct 03; 37(10):1231-43. PubMed ID: 21438702
    [Abstract] [Full Text] [Related]

  • 34. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system.
    Serratoni M, Newton M, Booth S, Clarke A.
    Eur J Pharm Biopharm; 2007 Jan 03; 65(1):94-8. PubMed ID: 17056237
    [Abstract] [Full Text] [Related]

  • 35. The behavior of different carrageenans in pelletization by extrusion/spheronization.
    Thommes M, Kleinebudde P.
    Pharm Dev Technol; 2008 Jan 03; 13(1):27-35. PubMed ID: 18300097
    [Abstract] [Full Text] [Related]

  • 36. Extrusion/spheronization--effect of moisture content and spheronization time on pellet characteristics.
    Iyer RM, Augsburger LL, Pope DG, Shah RD.
    Pharm Dev Technol; 1996 Dec 03; 1(4):325-31. PubMed ID: 9552316
    [Abstract] [Full Text] [Related]

  • 37. The evaluation of modified microcrystalline cellulose for the preparation of pellets with high drug loading by extrusion/spheronization.
    Podczeck F, Knight PE, Newton JM.
    Int J Pharm; 2008 Feb 28; 350(1-2):145-54. PubMed ID: 17905548
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of tableting and tablet properties of Kollidon SR: the influence of moisture and mixtures with theophylline monohydrate.
    Hauschild K, Picker-Freyer KM.
    Pharm Dev Technol; 2006 Feb 28; 11(1):125-40. PubMed ID: 16544916
    [Abstract] [Full Text] [Related]

  • 39. Co-processed MCC-Eudragit® E excipients for extrusion-spheronization.
    Goyanes A, Souto C, Martínez-Pacheco R.
    Eur J Pharm Biopharm; 2011 Nov 28; 79(3):658-63. PubMed ID: 21827853
    [Abstract] [Full Text] [Related]

  • 40. Insights into the functionality of pelletization aid in pelletization by extrusion-spheronization.
    Sarkar S, Heng PW, Liew CV.
    Pharm Dev Technol; 2013 Feb 28; 18(1):61-72. PubMed ID: 21981607
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.